Internal Medicine, Endocrinology, Diabetes, & Metabolism · Mesquite, TX
NPI
1487679213
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1621 N. Beltline Rd, Suite A
Mesquite, TX, 75149
Phone (972) 682-5700
Groups this clinician bills Medicare through
Medicare paid, 2024
$608K
21,303 services
Medicare patients, 2024
1,548
Average age 73
Drug cost, 2024
$4.6M
10,843 prescriptions
Company payments, 2025
$60K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sumana Gangi was code J0897 (injection, denosumab, 1 mg), 4,800 times for 53 patients. In total Sumana Gangi billed 21,303 services in 46 codes, and Medicare paid $608K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,800 | 53 | $20.40 | $98K |
| 99214 Office E&M - Established | Office | 2,095 | 859 | $88.10 | $185K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,927 | 504 | $31.08 | $60K |
| 36415 Venipuncture Blood Collection | Office | 1,776 | 940 | $8.65 | $15K |
| 80053 Clinical Chemistry | Office | 1,330 | 729 | $9.89 | $13K |
| 84443 Clinical Chemistry | Office | 1,173 | 697 | $16.44 | $19K |
| 83036 Blood Count | Office | 1,072 | 568 | $9.49 | $10K |
| 84439 Clinical Chemistry | Office | 1,030 | 599 | $8.84 | $9,105 |
| 84480 Clinical Chemistry | Office | 769 | 456 | $13.90 | $11K |
| 82947 Clinical Chemistry | Office | 723 | 397 | $3.82 | $2,765 |
| 80061 Clinical Chemistry | Office | 711 | 428 | $13.07 | $9,293 |
| 95251 Test - Miscellaneous | Office | 680 | 270 | $24.49 | $17K |
| 82306 Clinical Chemistry | Office | 490 | 396 | $29.01 | $14K |
| 85025 Blood Count | Office | 371 | 250 | $7.61 | $2,823 |
| 99213 Office E&M - Established | Office | 256 | 190 | $61.14 | $16K |
By year: 2022 $611K for 23,632 services; 2023 $636K for 21,538 services; 2024 $608K for 21,303 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,776 | 940 | $8.65 | $15K |
| 80053 Clinical Chemistry | 1,330 | 729 | $9.89 | $13K |
| 84443 Clinical Chemistry | 1,173 | 697 | $16.44 | $19K |
| 83036 Blood Count | 1,072 | 568 | $9.49 | $10K |
| 84439 Clinical Chemistry | 1,030 | 599 | $8.84 | $9,105 |
| 84480 Clinical Chemistry | 769 | 456 | $13.90 | $11K |
| 82947 Clinical Chemistry | 723 | 397 | $3.82 | $2,765 |
| 80061 Clinical Chemistry | 711 | 428 | $13.07 | $9,293 |
| 82306 Clinical Chemistry | 490 | 396 | $29.01 | $14K |
| 85025 Blood Count | 371 | 250 | $7.61 | $2,823 |
Medicare prescription drug claims, 2024
In 2024, the drug Sumana Gangi prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,163 prescriptions and refills. In total Sumana Gangi wrote 10,843 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,163 | 2,690 | 354 | $8,764 |
| Ozempic Semaglutide | 611 | 1,003 | 181 | $965K |
| Metformin Hcl Generic | 493 | 1,193 | 159 | $3,275 |
| Atorvastatin Calcium Generic | 360 | 916 | 127 | $2,220 |
| Glimepiride Generic | 335 | 766 | 105 | $2,162 |
| Jardiance Empagliflozin | 325 | 711 | 115 | $413K |
| Mounjaro Tirzepatide | 325 | 518 | 90 | $550K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 261 | 609 | 117 | $31K |
| Tresiba Flextouch U-100 Insulin Degludec | 259 | 638 | 101 | $234K |
| Gabapentin Generic | 224 | 412 | 85 | $4,083 |
| Farxiga Dapagliflozin Propanediol | 220 | 381 | 67 | $201K |
| Trulicity Dulaglutide | 216 | 347 | 80 | $337K |
| Methimazole Generic | 207 | 396 | 59 | $1,684 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 196 | 494 | 95 | $36K |
| Synthroid Levothyroxine Sodium | 191 | 391 | 51 | $16K |
Brand drugs: 4,955 claims; generic drugs: 5,059 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sumana Gangi $60K ($52K in general payments such as food, travel and fees and $7,981 for research) from 33 companies. The largest payer was Lilly USA, LLC with $44K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 73 | $44K |
| Amgen Inc. AMGN | 11 | $8,172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $5,600 |
| CeQur Corporation | 2 | $595 |
| Eli Lilly and Company LLY | 1 | $409 |
| Novo Nordisk Inc NVO | 12 | $349 |
| Madrigal Pharmaceuticals MDGL | 10 | $217 |
| Medtronic, Inc. MDT | 7 | $181 |
| Abbott Laboratories ABT | 8 | $170 |
| Abbvie Inc. ABBV | 11 | $161 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.